title: [Consequences of the German anticorruption law for sponsorship at university hospitals].
abstract: The cooperation between the pharmaceutical industry and clinical researchers has become an increasingly important public issue. Concerns are mainly focused around independence of clinical research and the dedication of clinical researches solely to the welfare of their patients. The declining public confidence in self-regulation has finally resulted in new legislation that has major impact on clinical research in Germany particularly at academic centers.
authors.affiliation: Abteilung für Hämatologie, Onkologie und Immunologie des Zentrums für Innere Medizin, Klinikum, Philipps-Universität Marburg, Baldingerstrasse, D-35033 Marburg, Deutschland. neubauer@mailer.uni-marburg.de
authors.forename: A
authors.initials: A
authors.lastname: Neubauer
mesh_terms: D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence; D016265:Conflict of Interest / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D005607:Fraud / Q000331:legislation & jurisprudence*; D005858:Germany; D006785:Hospitals, University / Q000331:legislation & jurisprudence*; D006801:Humans; D012109:Research Support as Topic / Q000331:legislation & jurisprudence*